Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ORITAVANCIN vs OSILODROSTAT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ORITAVANCIN vs OSILODROSTAT: Safety Overview

Metric ORITAVANCIN OSILODROSTAT
Total FAERS Reports 884 1,626
Deaths Reported 29 191
Death Rate 3.3% 11.7%
Hospitalizations 157 526
Average Patient Age 55.9 yrs 56.3 yrs
% Female Patients 52.2% 70.8%
FDA Approval Date N/A Mar 6, 2020
Manufacturer Melinta Therapeutics, LLC Recordati Rare Diseases, Inc.
Route INTRAVENOUS ORAL
Marketing Status N/A Prescription